Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BIO-TECHNE (TECH) Equity Ratio: 2010-2025

Historic Equity Ratio for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to 0.78.

  • BIO-TECHNE's Equity Ratio fell 0.45% to 0.78 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78, marking a year-over-year decrease of 0.45%. This contributed to the annual value of 0.75 for FY2025, which is 1.96% down from last year.
  • Latest data reveals that BIO-TECHNE reported Equity Ratio of 0.78 as of Q3 2025, which was up 3.74% from 0.75 recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Equity Ratio registered a high of 0.78 during Q3 2024, and its lowest value of 0.69 during Q2 2021.
  • Its 3-year average for Equity Ratio is 0.75, with a median of 0.75 in 2025.
  • Per our database at Business Quant, BIO-TECHNE's Equity Ratio rose by 14.95% in 2021 and then decreased by 6.99% in 2023.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Equity Ratio stood at 0.74 in 2021, then rose by 4.63% to 0.77 in 2022, then declined by 6.99% to 0.72 in 2023, then climbed by 8.24% to 0.78 in 2024, then declined by 0.45% to 0.78 in 2025.
  • Its Equity Ratio was 0.78 in Q3 2025, compared to 0.75 in Q2 2025 and 0.76 in Q1 2025.